(Q44010170)

28 November 2017

title

Decreasing mortality from non-Hodgkin lymphoma in Australia (English)

1 reference

28 November 2017

1 reference

M Coory

1

1 reference

28 November 2017

D Gill

series ordinal

2

1 reference

28 November 2017

publication date

1 December 2008

1 reference

Internal Medicine Journal

28 November 2017

published in

1 reference

28 November 2017

volume

38

1 reference

28 November 2017

issue

12

1 reference

28 November 2017

page(s)

921-924

1 reference

Epidemiology and etiology of non-Hodgkin lymphoma--a review

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

The non-Hodgkin lymphomas: a review of the epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

Follicular lymphoma international prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01809.X

10.1111/J.1445-5994.2008.01809.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference